Oncology

Headache Relief Shampoo Voted #1 Best New Product in 2019

headache relief shampoo bottles

Dr. D’s Medicated Headache Relief Shampoo is now available. This medicated shampoo will help alleviate headaches simply by soaking it on your head. Finding relief from minor to severe headaches shouldn’t always involve reaching for a bottle of pills. Dr. D is here to give you another option. Our proprietary formula will leave your head feeling better.

BUY NOW! http://headachereliefshampoo.com/product/headache-relief-shampoo/

January 1, 2019Comments OffHeadache Drug Trial | Headache Relief | Headache Shampoo | Headache Study | Headache Therapy
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
Conditions:   Breast Cancer;   Breast Cancer Female
Intervention:   Procedure: mHealth US-breast biopsy
Sponsor:   Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 1, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
Conditions:   Brain Metastases;   Brain Metastases, Adult;   Metastatic Brain Tumor;   Metastatic Brain Cancer
Intervention:   Diagnostic Test: CEST-MRF
Sponsor:   Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 30, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Efficacy and Safety of REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
Condition:   Familial Adenomatous Polyposis
Interventions:   Drug: REC-4881;   Drug: Placebo
Sponsor:   Recursion Pharmaceuticals Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 30, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML
Condition:   Acute Myeloid Leukemia
Interventions:   Drug: Vyxeos;   Drug: Gemtuzumab Ozogamicin
Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   Jazz Pharmaceuticals
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 29, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
F-Tryptophan PET/CT in Human Cancers
Conditions:   Intracranial Glioma;   Metastatic Brain Tumor;   Breast Cancer;   Neuroendocrine Tumors
Intervention:   Drug: 1-(2-[18F]FLUOROETHYL)-L-Tryptophan
Sponsor:   Barbara Ann Karmanos Cancer Institute
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 28, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative
Conditions:   Relapsed Hepatoblastoma;   Refractory Hepatoblastoma
Intervention:   Other: Biospecimen collection
Sponsor:   Children’s Hospital Medical Center, Cincinnati
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 28, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
Conditions:   Multiple Myeloma;   Amyloidosis;   Plasma Cell Leukemia
Intervention:  
Sponsor:   University of Alabama at Birmingham
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 28, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage
Conditions:   Breast Cancer;   BRCA Mutation
Interventions:   Drug: Tranexamic acid;   Drug: Normal saline
Sponsors:   Northwestern University;   Saint Joseph Hospital, Chicago, Illinois;   Northwestern Memorial Hospital
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 27, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
PRISM: Pre-Operative Radiotherapy and Immunotherapy for Sinonasal Melanoma
Condition:   Sinonasal Melanoma
Intervention:   Procedure: Surgical resection
Sponsor:   M.D. Anderson Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 27, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
CRC Detection Reliable Assessment With Blood
Conditions:   Colorectal Cancer;   Adenomas Colon;   Colon Cancer;   Rectal Cancer;   Colon Neoplasm;   Colon Lesion;   Colon Disease;   Colon Polyp;   Polyps;   Adenoma;   Rectal Diseases;   Rectal Polyp;   Gastrointestinal Neoplasms;   Intestinal Neoplasms;   Colonic Diseases, Functional;   Intestinal Disease
Intervention:   Diagnostic Test: Next-Gen CRC Screening Test
Sponsor:   Epigenomics, Inc
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 23, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine